37
Views
4
CrossRef citations to date
0
Altmetric
Perspective

Challenges and opportunities: what we are learning from the clinical natalizumab experience

Pages 605-615 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mathias Buttmann & Peter Rieckmann. (2008) Treating multiple sclerosis with monoclonal antibodies. Expert Review of Neurotherapeutics 8:3, pages 433-455.
Read now

Articles from other publishers (2)

Giuseppe TridenteGiuseppe Tridente. 2014. Adverse Events with Biomedicines. Adverse Events with Biomedicines 267 275 .
Kenneth P. Johnson. (2007) Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis. The Neurologist 13:4, pages 182-187.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.